Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial

IMPORTANCE: Post-hoc analyses from DRCR.net randomized trial comparing aflibercept, bevacizumab, and ranibizumab for diabetic macular edema (DME) might influence interpretation of study results. OBJECTIVE: To provide additional post-hoc clinically relevant outcomes comparing three anti-VEGF agents f...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JAMA Ophthalmol
Auteurs principaux: Jampol, Lee M., Glassman, Adam R., Bressler, Neil M., Wells, John A., Ayala, Allison R.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5567802/
https://ncbi.nlm.nih.gov/pubmed/27711918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2016.3698
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires